The FAA administrator's comments come on the eve of his visit to Boeing facilities outside Seattle, Washington. While there, he's scheduled to meet with Boeing executives and...Airlinesread more
CBS, CNN and other major media companies are starting to pull e-cigarette advertising off their airways, as the death toll from a mysterious vaping-related illness continues...Health and Scienceread more
Investors largely expected the FOMC to cut rates by a quarter point.The Fedread more
As the Fed was meeting to consider cutting interest rates, it lost control of the very benchmark rate that it manages.Market Insiderread more
For the past six years, Facebook has tried over and over to release a hardware product that consumers will want, and it has never succeeded.Technologyread more
AT&T is considering selling DirecTV, according to a report in the Wall Street Journal.Technologyread more
The Fed cut interest rates by a quarter point, but it also reaffirmed its rate cut was meant to serve as insurance for the economy.Market Insiderread more
President Barack Obama spoke at an event in San Francisco on Wednesday hosted by software company Splunk and addressed how tech can help solve problems.Technologyread more
Disney CEO Bob Iger writes in his autobiography that he believes he would have discussed combining Disney with Apple had Steve Jobs lived.Technologyread more
The Facebook CEO will talk to policymakers "about future internet regulation," according to a spokesperson.Technologyread more
Microsoft shares rose 1% after hours as it announced plans to raise its dividend and authorized as much as $40 billion to buy back shares.Technologyread more
As the use of personalized medicine continues to widen, a Massachusetts-based nonprofit organization is looking to get really personal and it's paying good money for healthy stool samples.
The company, OpenBiome, is willing to pay as much as $250 for a week's worth of donations of healthy stool samples, or $13,000 a year, according to The Washington Post.
However, donors must undergo vigorous questioning and stool testing to make the cut.
Over the last four years, only 4 percent of interested donors have passed the screening process, co-founder Mark Smith told WaPo.
The sample is used to treat patients who are sick with infections of a bacteria called C. difficile. It is administered, in frozen form via endoscopy or swallowed capsules.
OpenBiome has already shipped about 2,000 treatments to nearly 200 hospitals in the U.S., according to The Post.
"You're usually helping three or four patients out with each sample, and we keep track of that and let you know," Smith said.
Click here to read the full report from The Post.